thymusI am taken by the urgency on page 6 of prospectus"The...

thymus

I am taken by the urgency on page 6 of prospectus
"The directors believe it is critical that Tissue Therapies move quickly to maximise the significant commercial opportunities now open to the company and in doing so, further enhance potential shareholder value."

If we are the regulatory sponsor and the manufacturer.
We only need the distributer and retailer. The product and experts and patients in need, are all in alignment I expect Tissue Therapies will benefit more than 15%.

Launching early 2012 in EU. The opportunity is here and now.